메뉴 건너뛰기




Volumn 117, Issue 10, 2011, Pages 2778-2782

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: A multicenter survival analysis of 53 patients

(28)  Arnaud, Laurent a,b   Hervier, Baptiste a,c   Néel, Antoine d   Hamidou, Mohamed A d   Kahn, Jean Emmanuel e   Wechsler, Bertrand a   Pérez Pastor, Gemma f   Blomberg, Bjørn g   Fuzibet, Jean Gabriel h   Dubourguet, François i   Marinho, António j   Magnette, Catherine k   Noel, Violaine l   Pavic, Michel m   Casper, Jochen n   Beucher, Anne Bérangère o   Costedoat Chalumeau, Nathalie a   Aaron, Laurent p   Salvatierra, Juan q   Graux, Carlos r   more..

b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; IMATINIB; INFLIXIMAB; METHOTREXATE; PEGINTERFERON ALPHA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SUNITINIB; VINBLASTINE;

EID: 79953124751     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-06-294108     Document Type: Article
Times cited : (317)

References (19)
  • 1
    • 0000646890 scopus 로고
    • Über lipoidgranulomatose
    • Chester W. Über lipoidgranulomatose. Virchows Arch Pathol Anat. 1930;279:561-602.
    • (1930) Virchows Arch Pathol Anat , vol.279 , pp. 561-602
    • Chester, W.1
  • 4
    • 60349106164 scopus 로고    scopus 로고
    • Erdheim-Chester disease: Case report with unique postmortem magnetic resonance imaging, highresolution radiography, and pathologic correlation
    • de Abreu MR, Castro MO, Chung C, et al. Erdheim-Chester disease: case report with unique postmortem magnetic resonance imaging, highresolution radiography, and pathologic correlation. Clin Imaging. 2009;33(2):150-153.
    • (2009) Clin Imaging , vol.33 , Issue.2 , pp. 150-153
    • De Abreu, M.R.1    Castro, M.O.2    Chung, C.3
  • 6
    • 27644519727 scopus 로고    scopus 로고
    • Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-α
    • DOI 10.1182/blood-2005-06-2238
    • Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-α. Blood. 2005;106(9):2992-2994. (Pubitemid 41565890)
    • (2005) Blood , vol.106 , Issue.9 , pp. 2992-2994
    • Braiteh, F.1    Boxrud, C.2    Esmaeli, B.3    Kurzrock, R.4
  • 7
    • 33750297107 scopus 로고    scopus 로고
    • Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: Results in eight patients
    • DOI 10.1002/art.22165
    • Haroche J, Amoura Z, Trad SG, et al. Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum. 2006;54(10):3330-3336. (Pubitemid 44622105)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.10 , pp. 3330-3336
    • Haroche, J.1    Amoura, Z.2    Trad, S.G.3    Wechsler, B.4    Cluzel, P.5    Grenier, P.A.6    Piette, J.-C.7
  • 8
    • 78549269492 scopus 로고    scopus 로고
    • Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease
    • Aouba A, Georgin-Lavialle S, Pagnoux C, et al. Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood. 2010;116(20):4070- 4076.
    • (2010) Blood , vol.116 , Issue.20 , pp. 4070-4076
    • Aouba, A.1    Georgin-Lavialle, S.2    Pagnoux, C.3
  • 10
    • 45949102275 scopus 로고    scopus 로고
    • Imatinib mesylate for platelet-derived growth factor receptor-beta- positive Erdheim-Chester histiocytosis
    • Haroche J, Amoura Z, Charlotte F, et al. Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis. Blood. 2008;111(11):5413-5415.
    • (2008) Blood , vol.111 , Issue.11 , pp. 5413-5415
    • Haroche, J.1    Amoura, Z.2    Charlotte, F.3
  • 11
    • 0037367862 scopus 로고    scopus 로고
    • Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease
    • Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin- 6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol. 2003;21(2):232-236. (Pubitemid 36519571)
    • (2003) Clinical and Experimental Rheumatology , vol.21 , Issue.2 , pp. 232-236
    • Mossetti, G.1    Rendina, D.2    Numis, F.G.3    Somma, P.4    Postiglione, L.5    Nunziata, V.6
  • 12
    • 0035818546 scopus 로고    scopus 로고
    • Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation [8]
    • Boissel N, Wechsler B, Leblond V. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med. 2001;135(9):844-845. (Pubitemid 33051276)
    • (2001) Annals of Internal Medicine , vol.135 , Issue.9 , pp. 844-845
    • Boissel, N.1    Wechsler, B.2    Leblond, V.3
  • 13
    • 67650709449 scopus 로고    scopus 로고
    • Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: Magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients
    • Haroche J, Cluzel P, Toledano D, et al. Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients. Circulation. 2009;119(25):e597-e598.
    • (2009) Circulation , vol.119 , Issue.25
    • Haroche, J.1    Cluzel, P.2    Toledano, D.3
  • 14
    • 70349774433 scopus 로고    scopus 로고
    • 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease
    • Arnaud L, Malek Z, Archambaud F, et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128-3138.
    • (2009) Arthritis Rheum , vol.60 , Issue.10 , pp. 3128-3138
    • Arnaud, L.1    Malek, Z.2    Archambaud, F.3
  • 16
    • 77951494464 scopus 로고    scopus 로고
    • Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings
    • Drier A, Haroche J, Savatovsky J, et al. Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology. 2010;255(2):586-594.
    • (2010) Radiology , vol.255 , Issue.2 , pp. 586-594
    • Drier, A.1    Haroche, J.2    Savatovsky, J.3
  • 18
    • 77957882897 scopus 로고    scopus 로고
    • Erdheim-Chester disease: CT findings of thoracic involvement
    • Brun AL, Touitou-Gottenberg D, Haroche J, et al. Erdheim-Chester disease: CT findings of thoracic involvement. Eur Radiol. 2010;20(11):2579-2587.
    • (2010) Eur Radiol , vol.20 , Issue.11 , pp. 2579-2587
    • Brun, A.L.1    Touitou-Gottenberg, D.2    Haroche, J.3
  • 19
    • 78249272990 scopus 로고    scopus 로고
    • Pulmonary involvement in Erdheim-Chester disease: A single-center study of thirty-four patients and a review of the literature
    • Arnaud L, Pierre I, Beigelman-Aubry C, et al. Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum. 2010;62(11):3504-3512.
    • (2010) Arthritis Rheum , vol.62 , Issue.11 , pp. 3504-3512
    • Arnaud, L.1    Pierre, I.2    Beigelman-Aubry, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.